The following is a brief review of the model as proposed and currently in use in several laboratories. Let f(t) be an unknown function of time, t, representing myocardial CPK appearance in the distribution space, and let E(t) be the serum CPK value at time T. In addition, let kd be the first order decay parameter (which by convention is negative) which represents CPK disappearance. Then, the rate of change of serum CPK activity (dE/dt) at any time, t, is equal to the difference between the amount appearing peripherally (f(t) ) and the amount eliminated from the distribution space (kdE):
mental mathematical model representing a biological system (acute myocardial infarction) in which CPK appears in the blood and is eventually degraded. From this model they developed a method for estimation of the size of a volume of infarcted myocardium.'-3 This method would seem ideally suited for estimating the acute effect of an intervention on infarct size, and several investigators have proposed doing so. [4] [5] [6] [7] [8] Up to this time, the literature on enzymatic estimation of infarct size has emphasized the situations in which it should be useful. However, there is little discussion of the potential limitation of this method. Therefore, we thought it would be useful to review the original work of Shell and to determine if any limitations existed, with particular emphasis on the sensitivity of infarct size estimation to the observed variations in model parameters.
Mathematical Model
A mathematical model relating serum creatine phosphokinase (CPK) to infarct size has been proposed by Shell and coworkers.1' 2 The model depicts serum enzyme activity as a function of myocardial release and first order decay. In addition, Shell and coworkers assumed that the releasing function was an unknown function of time. They considered as parameters the decay rate, the fraction of CPK released, the fraction of the body weight equivalent to the enzyme distribution space, and the amount of CPK depleted per gram of myocardium. They then applied this model to laboratory and clinical evaluation by studying both dogs subjected to sustained occlusion of the left anterior descending (LAD) coronary artery and patients with uncomplicated acute myocardial infarction.
The following is a brief review of the model as proposed and currently in use in several laboratories. Let f(t) be an unknown function of time, t, representing myocardial CPK appearance in the distribution space, and let E(t) be the serum CPK value at time T. In addition, let kd be the first order decay parameter (which by convention is negative) which represents CPK disappearance. Then, the rate of change of serum CPK activity (dE/dt) at any time, t, is equal to the difference between the amount appearing peripherally (f(t) ) and the amount eliminated from the distribution space (kdE):
The estimation of CPK released from the myocardium between time 0 and time T is then obtained by integrating f(t) from t = 0 to t = T:
The enzyme appearance function, fT f(t)dt, can be used to estimate grams of infarcted myocardium when knowledge of the distribution space, the fraction of cellular CPK which appears in blood, and the total EDITORIALS CPK is k,z and the total CPK per gram of tissue is CPK,). The estimated infarct size in grams is then: Table 2 illustrates the variation in fractional release as recalculated from the data in reference 2. This proportion (CPKR/CPKD = k,,) can be determined from the published serial enzyme values, integrals, body weights, grams infarct (based on myocardial depletion), and the recommended mean parameters.2 From these data, estimation of infarct sizes and peripheral recovery of enzyme (CPKR/CPKD) can be determined. The proportion of enzyme which appears peripherally, as recalculated from published data,2 is 32.2% + 7.6% (mean ± 1 SD), with a range of absolute recoveries of 20%-46%. However, when fT f(t)dt is calculated from the available data, a significant discrepancy can be noted between the published and the recalculated integral values for dogs 4-8. The correct values in these animals are associated with the most significant differences in the calculation of the CPKH/CPKD. The mean ±1 SD is equal to 45.7% ± 17.3%, with a range of values extending from 23%-76% recovery in the distribution space.
The recalculated CPKR/CPKD was determined without utilizing the percent recovery parameter, and the computation of f,5* f(t)dt involved only the reported serial enzyme values and the recommended kd of -0.0045 minml. Therefore, to achieve the lower integrated values from the published serial enzyme values, it would be necessary to use a kd less than the reported mean minus 1 SD. The possibility of a wide variation in CPKR/CPKD suggests that disproportionate amounts of CPK may be released compared to the actual amount of damage sustained by the myocardium. In figure 1, The relationship between infarct size determined on the basis of changes in serum CPK activity (ordinate) and infarct size determined on the basis of depletion of myocardial CPK activity 24 hours after coronary artery occlusion (abscissa 
